Ticker > Company >

Procter&Gamble Healt share price

Procter & Gamble Health Ltd.

NSE: PGHL BSE: 500126 SECTOR: Pharmaceuticals & Drugs  94k   366   39

5085.00
-7.55 (-0.15%)
BSE: 22 Nov 04:00 PM

Price Summary

Today's High

₹ 5161.4

Today's Low

₹ 5078.75

52 Week High

₹ 5835.95

52 Week Low

₹ 4640.3

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

8440.79 Cr.

Enterprise Value

8196.43 Cr.

No. of Shares

1.66 Cr.

P/E

38.77

P/B

13.79

Face Value

₹ 10

Div. Yield

5.07 %

Book Value (TTM)

₹  368.71

CASH

244.36 Cr.

DEBT

0 Cr.

Promoter Holding

51.82 %

EPS (TTM)

₹  131.17

Sales Growth

-6.37%

ROE

31.58 %

ROCE

42.52%

Profit Growth

-12.42 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Procter & Gamble Health Ltd.

Seven seas evion nasvision Polybion Livogen Neurobion

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-6.37%
3 Year4.5%
5 Year6.28%

Profit Growth

1 Year-12.42%
3 Year4.37%
5 Year-24.85%

ROE%

1 Year31.58%
3 Year31.64%
5 Year27.55%

ROCE %

1 Year42.52%
3 Year42.34%
5 Year37.02%

Debt/Equity

0

Price to Cash Flow

36.97

Interest Cover Ratio

380.6111

CFO/PAT (5 Yr. Avg.)

1.05940124306116

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 51.82 0.00
Jun 2024 51.82 0.00
Mar 2024 51.82 0.00
Dec 2023 51.82 0.00
Sep 2023 51.82 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 31.6447323186025% over the past 3 years.
  • Company has been maintaining healthy ROCE of 42.343934989648% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 380.6111.
  • The Company has been maintaining an effective average operating margins of 23.8088078746521% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -158.5615 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.05940124306116.
  • The company has a high promoter holding of 51.82%.

 Limitations

  • The company has shown a poor profit growth of 4.36547652430048% for the Past 3 years.
  • The company has shown a poor revenue growth of 4.50393286092057% for the Past 3 years.
  • The company is trading at a high PE of 38.77.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 304.93 309.97 252.48 283.88 313.41
Total Expenditure 216.27 208.32 185.04 235.63 199.37
Operating Profit 88.66 101.65 67.44 48.25 114.04
Other Income 6.05 5.18 2.27 2.13 3.28
Interest 0.18 0.19 0.15 0.2 0.15
Depreciation 6.48 6.92 6.84 7.16 5.77
Exceptional Items 0 0 0 -20.19 0
Profit Before Tax 88.05 99.72 62.72 22.83 111.4
Tax 22.48 27.65 16.16 6.05 29.07
Profit After Tax 65.57 72.07 46.56 16.78 82.33
Adjusted EPS (Rs) 39.5 43.42 28.05 10.11 49.6

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Jun 2020 Jun 2021 Jun 2022 Jun 2023 Jun 2024
Net Sales 1355.86 1008.73 1114.41 1229.62 1151.26
Total Expenditure 1041.52 762.71 846.73 904.94 845.26
Operating Profit 314.34 246.02 267.68 324.68 306
Other Income 69.96 18.1 13.19 18.39 15.63
Interest 0 0.8 0.42 0.77 0.72
Depreciation 29.45 30.04 27.08 28.1 27.4
Exceptional Items 0 0 0 0 -20.19
Profit Before Tax 354.85 233.28 253.37 314.2 273.32
Tax 100.77 56.48 60.85 84.73 72.34
Net Profit 254.08 176.8 192.52 229.47 200.98
Adjusted EPS (Rs.) 153.06 106.51 115.98 138.23 121.07

Balance Sheet (All Figures are in Crores.)

Particulars Jun 2020 Jun 2021 Jun 2022 Jun 2023 Jun 2024
Equity and Liabilities
Share Capital 16.6 16.6 16.6 16.6 16.6
Total Reserves 889.74 687.11 599.89 734.29 521.64
Borrowings 0 0 0 0 0
Other N/C liabilities 667.16 723.42 713.63 803 840.55
Current liabilities 538.62 550.68 607.73 679.08 625.3
Total Liabilities 2112.12 1977.81 1937.85 2232.97 2004.09
Assets
Net Block 97.92 100.96 109.06 141.72 126.6
Capital WIP 21.45 39.15 40.6 32.49 5.89
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 724.61 795.9 801.72 885.23 939.09
Other N/C Assets 3.3 2.95 2.6 2.25 1.9
Current Assets 1264.84 1038.85 983.87 1171.28 930.61
Total Assets 2112.12 1977.81 1937.85 2232.97 2004.09
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Jun 2020 Jun 2021 Jun 2022 Jun 2023 Jun 2024
Profit from operations 354.85 233.28 253.37 314.2 273.32
Adjustment -12.16 40.89 27.31 41.49 52.27
Changes in Assets & Liabilities -5.73 41.22 -47.3 -30.02 -12.12
Tax Paid -101.59 -68.13 -63.86 -89.66 -85.18
Operating Cash Flow 235.37 247.26 169.52 236.01 228.29
Investing Cash Flow 164.64 -32.27 -25.54 -21.5 -6.87
Financing Cash Flow -883.41 -386.63 -288.63 -98.47 -418.11
Net Cash Flow -483.4 -171.64 -144.65 116.04 -196.69

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 51.82 51.82 51.82 51.82 51.82
procter and gamble overse... 51.82 51.82 51.82 51.82 51.82
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 48.18 48.18 48.18 48.18 48.18
icici prudential mnc fund... - - - - 2.61
investor education and pr... 0.33 - 0.36 0.36 0.36
lici asm non par 2.41 2.10 - - 2.49
nippon life india trustee... 3.60 - 3.98 3.98 4.10
uti-mnc fund - 1.27 - - 1.89
icici prudential s&p bse ... - - 2.10 2.60 -
life insurance corporatio... - - 2.24 2.45 -
uti - healthcare fund - - 1.64 1.87 -
hdfc small cap fund - 2.05 - - -
investor education and pr... - 0.36 - - -
nippon life india trustee... - 3.63 - - -
hdfc mutual fund - hdfc s... 2.04 - - - -

Ratings & Research Reports

Company Presentations

Company News

Procter&Gamble Healt - Quaterly Results 4 Nov, 5:52 PM Procter&Gamble Healt - Quaterly Results 4 Nov, 5:52 PM Procter&Gamble Healt - Quaterly Results 4 Nov, 5:52 PM Procter & Gamble Health informs about loss of share certificates 9 Oct, 12:17 PM Procter & Gamble Health informs about certificate 9 Oct, 12:15 PM Procter&Gamble Healt - Quaterly Results 21 Aug, 4:05 PM Procter&Gamble Healt - Quaterly Results 21 Aug, 4:05 PM Procter&Gamble Healt - Quaterly Results 21 Aug, 4:05 PM Procter&Gamble Healt - Quaterly Results 2 May, 8:01 PM Procter&Gamble Healt - Quaterly Results 2 May, 8:01 PM Procter & Gamble Hygiene and Health Care informs about disclosure 27 Mar, 10:08 AM Procter & Gamble Health informs about loss of share certificates 4 Mar, 11:13 AM Procter & Gamble Health informs about corporate action 6 Feb, 5:29 PM Procter&Gamble Healt - Quaterly Results 6 Feb, 4:44 PM Procter&Gamble Healt - Quaterly Results 6 Feb, 4:44 PM Procter&Gamble Healt - Quaterly Results 6 Feb, 4:44 PM Procter & Gamble Health informs about loss of share certificates 20 Jan, 1:13 PM Procter & Gamble Health informs about loss of share certificate 21 Dec, 4:39 PM Procter & Gamble Health informs about loss of share certificate 18 Dec, 12:17 PM Procter&Gamble Healt - Quaterly Results 3 Nov, 7:54 PM Procter&Gamble Healt - Quaterly Results 3 Nov, 7:54 PM Procter & Gamble Hygiene & Health Care informs about outcome of board meeting 30 Oct, 5:25 PM Procter & Gamble Health informs about loss of share certificates 21 Oct, 10:34 AM Procter & Gamble Health informs about disclosure 27 Sep, 12:35 PM Procter & Gamble Health to discontinue production of injections at Goa plant 27 Sep, 10:50 AM Procter&Gamble Healt - Quaterly Results 23 Aug, 8:31 PM Procter&Gamble Healt - Quaterly Results 23 Aug, 8:31 PM Procter & Gamble Health informs about issuance of duplicate share certificate 27 Jul, 9:02 AM Procter & Gamble Health reports 16% rise in Q3 net profit 16 May, 11:13 AM Procter&Gamble Healt - Quaterly Results 15 May, 8:16 PM Procter&Gamble Healt - Quaterly Results 15 May, 8:16 PM Procter & Gamble Health informs about resignation of executive director cum CFO 17 Mar, 1:05 PM Procter & Gamble Health informs about resignation of director 17 Mar, 12:37 PM Procter & Gamble Health informs about transcript of related party transactions 20 Feb, 4:46 PM Procter & Gamble Health informs about loss of share certificate 16 Feb, 4:24 PM Procter&Gamble Healt - Quaterly Results 5 Feb, 1:07 PM Procter&Gamble Healt - Quaterly Results 5 Feb, 1:07 PM Procter & Gamble Health informs about loss of share certificate 28 Jan, 12:43 PM Procter & Gamble Health informs about details of loss of certificate 29 Nov, 4:54 PM Procter&Gamble Healt - Quaterly Results 11 Nov, 7:35 PM Procter&Gamble Healt - Quaterly Results 11 Nov, 7:35 PM Procter & Gamble Hygiene and Health Care informs about loss of share certificate 4 Nov, 10:08 AM Procter & Gamble Health informs about annual report 1 Nov, 11:49 AM Procter & Gamble Health informs about issuance of duplicate share certificate 17 Sep, 9:56 AM Procter & Gamble Health informs about outcome of board meeting 29 Aug, 4:23 PM Procter&Gamble Healt - Quaterly Results 29 Aug, 3:16 PM Procter&Gamble Healt - Quaterly Results 29 Aug, 3:16 PM Procter&Gamble Healt - Quaterly Results 29 Aug, 3:16 PM Procter & Gamble Health informs about annual secretarial compliance report 29 Aug, 12:11 PM Procter & Gamble Health partners with Lakshya and Recycle India Foundation 6 Jun, 4:59 PM

Procter&Gamble Healt Stock Price Analysis and Quick Research Report. Is Procter&Gamble Healt an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Procter&Gamble Healt and its performance over the period of time. Procter&Gamble Healt stock price today is Rs 5094.8.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Procter&Gamble Healt cash from the operating activity was Rs 228.29 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Procter&Gamble Healt has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Procter&Gamble Healt , the EPS growth was -12.4155 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Procter&Gamble Healt has OPM of 26.5795736844848 % which is a good sign for profitability.
     
  • ROE: Procter&Gamble Healt have a healthy ROE of 31.5818 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Procter&Gamble Healt is Rs 5094.8. One can use valuation calculators of ticker to know if Procter&Gamble Healt share price is undervalued or overvalued.
Last Updated on:
Brief about Procter&Gamble Healt

Procter & Gamble Health Ltd. Financials: Check Share price, Balance Sheet, Annual report, and Quarterly Results for company analysis

Procter & Gamble Health Ltd. stock analysis page is a comprehensive resource for long-term investors searching for accurate information about the company. Our website provides investors with the necessary tools and resources, including share price, balance sheet, annual report, dividend, quarterly result, stock price, price chart, news, concall, transcripts, investor presentations, promoters, and shareholders analysis. These tools enable investors to make informed investment decisions that ensure long-term growth.

Procter & Gamble Health Ltd. Share Price Analysis:

Procter & Gamble Health Ltd.'s share price is a key indicator of the company's financial performance. As a potential investor, it's crucial to analyze the share price's trends and performance over time. Ticker stock analysis page provides investors with historical share price charts that track the company's performance over an extended period. This feature allows investors to monitor the stock's performance and identify trends that may impact future growth. Ticker's pre-built screening tools can assist investors in comparing Procter & Gamble Health Ltd.'s share price performance with its peers, enabling them to make informed investment decisions. A stock's share price is determined by a range of factors such as market sentiment, financial performance, and general economic conditions. 

Procter & Gamble Health Ltd. Balance Sheet Analysis:

Analyzing Procter & Gamble Health Ltd.'s balance sheet is an essential factor for investors interested in understanding the company's financial stability and health. The balance sheet's information provides important insights into the company's assets, liabilities, and shareholders' equity. Ticker provides access to Procter & Gamble Health Ltd.'s balance sheet as a downloadable document, which investors can use to perform an in-depth analysis. In addition, our pre-built screening tools can assist investors in analyzing the company's financial health and evaluating its long-term growth potential.

Procter & Gamble Health Ltd. Annual Report Analysis:

Procter & Gamble Health Ltd.'s annual report is a vital resource for investors interested in long-term investments. The report offers information on the company's strategic initiatives, future goals, and financial performance. Ticker offers investors access to the company's annual report as a downloadable document that they can use to perform an in-depth analysis. Our pre-built screening tools can also provide insights into the company's performance, making it easier for investors to make informed investment decisions.

Procter & Gamble Health Ltd. Dividend Analysis:

Investors interested in Procter & Gamble Health Ltd.'s stock should evaluate the company's dividend payout policies. The company's dividend payout trends are a crucial factor when assessing the stock's potential for long-term growth. Ticker features information on the company's dividend payout history, providing investors with valuable insights into the company's potential as a long-term investment option.

Procter & Gamble Health Ltd. Quarterly Results Analysis:

Procter & Gamble Health Ltd.'s quarterly results offer insights into the company's financial performance, including revenue, profit, and loss. Investors can use this information to assess the company's growth potential. Tickder features a downloadable copy of Procter & Gamble Health Ltd.'s quarterly results, which investors can use to make informed investment decisions. Our pre-built screening tools provide insights into the company's financial performance compared to its peers, allowing investors to evaluate its long-term growth potential.

Procter & Gamble Health Ltd. Stock Price Analysis:

Monitoring Procter & Gamble Health Ltd.'s stock prices regularly is crucial when assessing the company's financial performance. Our stock analysis page features current stock price updates, enabling investors to track market trends and identify potential investment opportunities. Ticker's pre-built screening tools can also help investors analyze the company's stock price performance compared to its peers, making it easier to make informed investment decisions. Our website provides pre-built screening tools to help investors analyze stock price and performance.

Procter & Gamble Health Ltd. Price Chart Analysis:

A visual representation of Procter & Gamble Health Ltd.'s share price trends over time is a valuable tool for long-term investors. The price chart allows investors to analyze the company's share price performance and identify any trends that could impact future growth. Our website provides investors with a price chart they can use for an in-depth analysis. Our pre-built screening tools can also assist investors in evaluating the company's long-term growth potential by analyzing its performance compared to its peers.

Procter & Gamble Health Ltd. News Analysis:

Keeping up with the latest news and developments that impact Procter & Gamble Health Ltd.'s stock is crucial for investors. Our website offers timely news articles related to the company, providing investors with up-to-date insights into its performance. The news section of our website features reliable information on significant events, regulatory changes, and other factors that could potentially impact the stock's performance. Ticker's pre-built screening tools can also provide investors with information about the company's global and local news.

Procter & Gamble Health Ltd. Concall Transcripts Analysis:

Procter & Gamble Health Ltd.'s concall transcripts offer investors insights into the company's future guidance and outlook. Our website provides access to these critical documents, enabling long-term investors to stay informed about the company's financial health and future growth. Our pre-built screening tools can also help investors perform an in-depth analysis of the information presented in the transcripts.

Procter & Gamble Health Ltd. Investor Presentations Analysis:

Procter & Gamble Health Ltd. prepares investor presentations to offer investors detailed information on the company's operations and financial performance. These presentations are valuable resources for long-term investors to study the company's strategic initiatives, providing necessary insights that could potentially impact the stock's value. Our website offers access to these presentations as downloadable documents that investors can use for an in-depth analysis. Our premium feature tools can also assist investors in performing a comprehensive analysis of the presented data.

Procter & Gamble Health Ltd. Promoters and Shareholders Analysis:

Understanding Procter & Gamble Health Ltd.'s promoters and shareholders is essential when assessing the viability of investing in its stock. Our stock analysis page provides vital information regarding the company's promoters and other shareholders. Long-term investors must consider these elements before making any investment decisions. Our pre-built screening tools can assist investors in analyzing the company's shareholding patterns and evaluating its growth potential.

Read More
X